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Proteome proﬁling is a type of quantitative analysis that reveals
level of protein expression in the sample. Proteome proﬁling by
using selected reaction monitoring is an approach for the
Chromosome-centric Human Proteome Project (C-HPP). Here we
describe dataset generated in the course of the pilot phase of
Russian part of C-HPP, which was focused on human Chr 18 pro-
teins. Proteome proﬁling was performed using stable isotope-
labeled standards (SRM/SIS) for plasma, liver tissue and HepG2
cells. Dataset includes both positive and negative results of protein
detection.
These data were partly discussed in recent publications,
“Chromosome 18 Transcriptome Proﬁling and Targeted Proteome
Mapping in Depleted Plasma, Liver Tissue and HepG2 Cells” [1] and
“Chromosome 18 transcriptoproteome of liver tissue and HepG2
Cells and targeted proteome mapping in depleted plasma: Update
2013” [2], supporting the accompanying publication “State of the
Chromosome 18-centric HPP in 2016: Transcriptome and Proteome
Proﬁling of Liver Tissue and HepG2 Cells” [3], and are deposited at
the ProteomeXchange via the PASSEL repository with the dataset
identiﬁer PASSEL: PASS00697 for liver and HepG2 cell line.
& 2016 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).vier Inc. This is an open access article under the CC BY license
isonis).







DSubject area Biologyore speciﬁc sub-
ject areaTargeted mass-spectrometric proteome proﬁling of liver and HepG2 cell lineype of data Figure, table, raw ﬁles (.d), skyline ﬁles (.sky)
ow data was
acquiredProteome proﬁling was performed using stable isotope-labeled standards
(SRM/SIS) for liver tissue and HepG2 cellsata format Raw
xperimental
factorsThe trypsin digestion was used.xperimental
featuresDigested samples were separated using the HPLC Agilent 1290 system
including pump and autosampler. Internal Standard were produced using
Overture (Protein Technologies, USA) or Hamilton Microlab STAR devices.
The quantitative SRM analysis was performed using Agilent 6495 Triple
Quadrupole (Agilent, USA) equipped with Jet Stream ionization source.ata source
locationInstitute of Biomedical Chemistry, Moscow, Russiaata accessibility Data is available within this article and at the ProteomeXchange via PASSEL
(http://proteomecentral.proteomexchange.org/cgi/GetDataset?
ID¼PXD004407).Value of the data
 This data characterizes the diversity of chromosome 18 protein species in liver tissue and HepG2
cell line using SRM.
 This data could be of interest to laboratories studying protein reference levels and cross-tissue
biological variability of proteome.
 This data could be useful for protein, peptide and transition selection for SRM-assay development.
 Dataset may be used as a test for automated SRM-data processing algorithms.1. Data
This dataset describes conditions of liver tissue and HepG2 cell line proteome proﬁling. Targeted
protein list included 268 proteins of chromosome 18. Data were automatically processed to quantify
proteins in the biosample. Dataset includes raw data, transition list, skyline ﬁles and sample pre-
paration instructions, available in PASSEL, 2 ﬁgures and Supplementary table with protein copy
numbers in liver tissue and HepG2 cell line.2. Experimental design, materials and methods
2.1. Sample preparation
The trypsin digestion of liver tissue and cell lysates was performed as described in Ponomarenko
et al. [2].
2.2. Peptide synthesis
The peptides were produced using the SOLiD-phase peptide synthesis on the Overture (Protein
Technologies, USA) or Hamilton Microlab STAR devices according to the method published in Hood
E.V. Ilgisonis et al. / Data in Brief 8 (2016) 1365–1369 1367et al. [4] . The isotope-labeled leucine (Fmoc–Leu–OH-13C6,15N) was used for isotope-labeled peptide
synthesis instead of the unlabeled leucine (Fmoc–Leu–OH) [5].
2.3. Transition list
List of peptides for 268 chromosome 18 proteins was generated manually using data about
occurrence of proteotypic peptides from proteomic repositories GPMdb, ProteinAtlas and PRIDE and
MaRiMba-criteria (protocol was described earlier in Supplementary note 2, Zgoda et al. [1]). For each
protein one “best-ﬂyer” peptide was chosen. For each peptide 3 the most intensive transitions [6]
were chosen using previous research results.
All 268 peptides were distributed over 3 SRM-assays (A–C) in equal parts according to their cal-
culated retention time to avoid interference.
LC-SRM Analysis was held as described earlier in Supplementary note 2, Zgoda et al. [1]. Each SRM
experiment was repeated in 3 technical runs. Each transition peak was characterized with the fol-
lowing variables: retention time, peak height, SIS/endogenous peak area ratio. No manual inspection
for to ﬁnd transitions that were similar to those in the target peptides or to reveal detected peptides
was held.
2.4. How to use data
Dataset is represented by several ﬁle types (Fig. 1). For re-using of the dataset and extraction
relevant information from it one can install freely-available and open source Windows client appli-
cation Skyline [7] (for each biosample there is one skyline ﬁle, including transitions and technical
runs info). It provides an opportunity to open raw data, visualize (Fig. 2) and analyze SRM data.
Besides it is possible to use proprietary software (Agilent MassHunter Workstation Software) for data
visualization.Fig. 1. Chromosome 18 proteome proﬁling dataset scheme.
Fig. 2. Screenshot of raw data visualization for HepG2 cell line, SRM-assay C using Skyline.
E.V. Ilgisonis et al. / Data in Brief 8 (2016) 1365–13691368All raw ﬁle are named using the following template:
1) Chromosome number: X18;
2) Sample type : HLV (liver tissue) or HPG (HepG2 cell line);
3) SRM-assay id: A, B or C; and
4) Technical run number: roo1, r002, r003.
For example, raw ﬁle name X18HPG_C-r002.d (Fig. 2). Skyline ﬁles also are named using these keys.2.5. Quantiﬁcation
Calibration curves were obtained for each of the desired peptides using the mixtures of puriﬁed
synthetic non-labeled peptides in the concentration range of 100–100 fmole/ml and its isotopically
labeled standards (SIS) were added at the concentration of 2 fmole/ml. All calibration curves were
linear in the range of 100–0.1 fmole/ml and showed the coefﬁcient of linear regression equal to 0.95.
Prior to the sample processing, the performance of the LC-SRM platforms used was validated by
obtaining the calibration curves of the corresponding set of SIS and synthetic non-labeled peptides.
Moreover, after ﬁve LC-SRM runs we veriﬁed the relevance of calibration by analyzing one of the
calibration peptide solution at 10 fmole/ml.
The detection limit was deﬁned as the lowest concentration determined on the linear part of
calibration curve. It varies for different peptides in the range from 100 amole/ml to 200 amole/ml.
Labeled (SIS)/target peptide peak area ratios were used to calculate the concentration of the tar-
geted peptide in a sample. Peak area ratios were obtained using Skyline software.
Cpept ¼Clab*Spept/Slab where Cpept – target peptide concentration, Clab – labeled peptide (SIS)
concentration (see Quantiﬁcation), Spept – area of target peptide peak, and Slab – area of labeled
peptide peak.
All calculated target peptide copy numbers for liver tissue and HepG2 are listed in the Supple-
mentary Table 1.
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